Allworth Financial’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61K | Buy |
1,423
+1,083
| +319% | +$1.22K | ﹤0.01% | 3791 |
|
|
2025
Q1 | $534 | Sell |
340
-63
| -16% | -$99 | ﹤0.01% | 3647 |
|
|
2024
Q4 | $774 | Sell |
403
-1,124
| -74% | -$2.16K | ﹤0.01% | 3479 |
|
|
2024
Q3 | $4.28K | Buy |
1,527
+709
| +87% | +$1.99K | ﹤0.01% | 2634 |
|
|
2024
Q2 | $2.32K | Buy |
818
+478
| +141% | +$1.35K | ﹤0.01% | 2855 |
|
|
2024
Q1 | $1.52K | Hold |
340
| – | – | ﹤0.01% | 2927 |
|
|
2023
Q4 | $1.09K | Sell |
340
-503
| -60% | -$1.62K | ﹤0.01% | 2919 |
|
|
2023
Q3 | $2.67K | Buy |
843
+783
| +1,305% | +$2.48K | ﹤0.01% | 2402 |
|
|
2023
Q2 | $299 | Buy |
+60
| New | +$299 | ﹤0.01% | 3021 |
|
|
2022
Q4 | – | Sell |
-37
| Closed | – | – | 2998 |
|
|
2022
Q3 | $0 | Buy |
+37
| New | – | ﹤0.01% | 2624 |
|